OFO
GILD icon

OneAscent Family Office’s Gilead Sciences GILD Stock Holding History

OneAscent Family Office’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Buy
4,802
+169
+4% +$22.3K 0.31% 71
2026
Q1 		$646K Sell
4,633
-74
-2% -$10.4K 0.45% 51
2025
Q4 		$578K Buy
4,707
+442
+10% +$53.7K 0.39% 62
2025
Q3 		$473K Sell
4,265
-87
-2% -$9.89K 0.39% 68
2025
Q2 		$483K Sell
4,352
-4,632
-52% -$493K 0.46% 52
2025
Q1 		$1.01M Buy
8,984
+3,871
+76% +$399K 0.94% 22
2024
Q4 		$472K Buy
+5,113
New +$460K 0.86% 24

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OneAscent Family Office's GILD Position: Q2 2026 in Review

OneAscent Family Office increased its Gilead Sciences (GILD) stake by 3.6% in Q2 2026, buying an estimated $22.3K and bringing the position to 4,802 shares worth $607K. The position accounts for 0.31% of the portfolio, ranked #71.

OneAscent Family Office first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.01M in Q1 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • OneAscent Family Office held 4,802 shares of Gilead Sciences worth $607K as of Q2 2026.
  • OneAscent Family Office bought 169 Gilead Sciences shares in Q2 2026, an estimated $22.3K.
  • Gilead Sciences made up 0.31% of OneAscent Family Office's portfolio in Q2 2026, its #71 holding.
  • OneAscent Family Office first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • OneAscent Family Office's Gilead Sciences position peaked at $1.01M in Q1 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on OneAscent Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.